Market research
ALINS.PA Intrasense SA
PA EUR Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 11M
- P/E ratio
- Not available
- Analyst target
- 0.2
- Dividend yield
- Not available
- Beta
- 0.57
Profile
Instrument facts
- Exchange
- PA
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- FR0011179886
- Market cap
- 11M
- P/E ratio
- Not available
- Analyst target
- 0.2
- Dividend yield
- Not available
- Beta
- 0.57
About
About Intrasense SA
Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A. was incorporated in 2004 and is headquartered in Montpellier, France. Intrasense S.A. operates as a subsidiary of Guerbet SA.
Research context
Intrasense SA appears in PyInvesting’s Paris Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ALINS.PA discussion.
5 years, 6 months ago
Intrasense SA is currently in a long term downtrend where the price is trading 36.3% below its 200 day moving average.
From a valuation standpoint, the stock is 97.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.1.
Intrasense SA's total revenue sank by 0.0% to $1M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-16K since the same quarter in the previous year.
Based on the above factors, Intrasense SA gets an overall score of 1/5.